Graf Akcie BIOC (Biocept Inc). Diskuze k akciím BIOC. Aktuální informace BIOC.

Základní informace o společnosti Biocept Inc (Akcie BIOC)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 52.4M
Hodnota podniku (EV) N/A
Tržby 54.901M
EBITDA N/A
Zisk -2.20
Růst v tržbách Q/Q 1,213.08 %
Růst v tržbách Y/Y 867.07 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.36
EV/Sales 0.96
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 0.95
P/FCF N/A
Price/Book 2.21
Účetní hodnota na akcii 1.77
Hotovost na akcii 1.07
FCF vůči ceně -12.73 %
Počet zaměstnanců 107
Tržba na zaměstnance 513.091k
Profit margin -64.84 %
Operating margin -3.53 %
Gross margin 22.30 %
EBIT margin -3.53 %
EBITDA margin -207.60 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -72.00 %
EPS - Očekávaný růst příští rok -109.30 %
Return on assets -4.87 %
Return on equity -8.72 %
ROIC -53.91 %
ROCE -4.73 %
Dluhy/Equity 1.00
Čistý dluh/EBITDA 2.74
Current ratio 3.72
Quick Ratio 3.41
Volatilita 5.28
Beta 0.56
RSI 50.64
Cílová cena analytiků 20
Známka akcie (dle analytiků) N/A
Insider ownership 0.04 %
Institutional ownership 10.83 %
Počet akcií 14.723M
Procento shortovaných akcií 5.83 %
Short ratio 2.06 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie BIOC

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$5.529$3.25$5.069$3.223$0.61$0.133
Cost Of Goods Sold$10.978$10.052$9.345$6.92$4.596$2.171
Gross Profit$-5.449$-6.801$-4.277$-3.697$-3.986$-2.037
Research And Development Expenses$4.697$4.469$3.365$2.713$2.858$4.498
SG&A Expenses$12.911$12.989$13.534$11.615$9.567$7.339
Other Operating Income Or Expenses------
Operating Expenses$28.586$27.509$26.243$21.248$17.021$14.007
Operating Income$-23.057$-24.259$-21.175$-18.025$-16.411$-13.874
Total Non-Operating Income/Expense$-2.081$-0.311$-0.431$-0.372$-0.537$-1.991
Pre-Tax Income$-25.138$-24.57$-21.606$-18.397$-16.948$-15.865
Income Taxes-$0.002$0.008$-0.002$0.002$0.002
Income After Taxes$-25.138$-24.572$-21.614$-18.395$-16.95$-15.866
Other Income------
Income From Continuous Operations$-25.138$-24.572$-21.614$-18.395$-16.95$-15.866
Income From Discontinued Operations------
Net Income$-25.26$-25.208$-21.614$-18.399$-16.95$-15.866
EBITDA$-22.284$-23.458$-20.599$-17.703$-16.149$-13.623
EBIT$-23.057$-24.259$-21.175$-18.025$-16.411$-13.874
Basic Shares Outstanding200000
Shares Outstanding200000
Basic EPS$-12.20$-90.10$-235.80$-576.58$-921.92$-3576.93
EPS - Earnings Per Share$-12.20$-90.10$-235.80$-576.58$-921.92$-3576.93
# 2020 2019 2018 2017 2016 2015
Current Ratio2.49921.3040.91291.31372.88584.1255
Long-term Debt / Capital-0.24460.47020.74270.44241.0482
Debt/Equity Ratio0.06470.53462.10486.22321.2535-22.0154
Gross Margin-98.56-209.2558-84.3706-114.7038-653.5809-1526.915
Operating Margin-417.051-746.3543-417.7572-559.246-2690.697-10399.07
EBIT Margin-417.051-746.3543-417.7572-559.246-2690.697-10399.07
EBITDA Margin-403.0634-721.7134-406.3989-549.2548-2647.836-10210.79
Pre-Tax Profit Margin-454.6937-755.9219-426.2685-570.795-2778.762-11891.12
Net Profit Margin-456.8926-775.5588-426.4189-570.8586-2779.025-11892.25
Asset Turnover0.31180.37140.68690.42530.05760.0203
Inventory Turnover Ratio14.293917.117418.738912.603913.159311.5009
Receiveable Turnover1.56752.06464.247224.991317.833612.5863
Days Sales In Receivables232.8603176.792685.939914.605120.46728.9997
ROE - Return On Equity-224.4343-807.6093-1667.681-2792.756-458.99677193.339
Return On Tangible Equity-224.4339-807.6072-1667.683-2792.818-458.99667193.23
ROA - Return On Assets-141.7614-280.8086-292.9125-242.7346-160.0988-241.6743
ROI - Return On Investment-224.4339-610.0905-883.601-718.4775-255.9419-346.454
Book Value Per Share2.04626.572710.97411.3033169.1296-44.6626
Operating Cash Flow Per Share68.7412134.4903277.7498333.36842459.4364-3250.7843
Free Cash Flow Per Share68.9045149.2469276.6265328.21242539.4449-3339.7854

Porovnání s konkurencí: Akcie BIOC

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BIOC 0.00 N/A 867.07 % -109.30 % -8.72 % 2.21 -64.84 %
Akcie EXAS N/A N/A 51.33 % -41.78 % -27.97 % 5.94 -56.90 %
Akcie MYGN N/A 1.40 3.71 % -80.00 % -10.91 % 2.64 -31.24 %
Akcie VCYT 0.00 N/A 39.93 % 137.50 % -9.04 % 7.20 -29.71 %

Nedávné obchody insiderů: Akcie BIOC

Jméno Obchod Cena Objem
Edward A. Neff
Director
Nákup
19 Oct 2016
$1.10 $249,999
Claire Reiss
10% owner
Nákup
19 Oct 2016
$1.10 $249,999
Margaret Faye Wilson
Director
Nákup
19 Oct 2016
$1.10 $15,000
Lyle J Arnold
SVP and Chief Scientific Officer
Nákup
19 Oct 2016
$1.10 $49,500
Veena Singh
Sr VP and Sr Med Director
Nákup
19 Oct 2016
$1.10 $11,000
Bruce Gerhardt
Director
Nákup
19 Oct 2016
$1.10 $55,000
Bruce A Huebner
Director
Nákup
19 Oct 2016
$1.10 $22,000
Timothy Kennedy
CFO, Sr V.P. Operations, and Sec.
Nákup
19 Oct 2016
$1.10 $39,999
Marsha Alpert Chandler
Director
Nákup
19 Oct 2016
$1.10 $5,000
Michael W. Nall
CEO and President
Nákup
19 Oct 2016
$1.10 $39,999
David F Hale
Director
Prodej
12 Jun 2020
$0.56 $650

Diskuze k akciím BIOC